Aetna Medicare AI Denials Face Legal Probe

Overview of the Investigation

Schall Law Firm Targets CVS and Aetna

The Schall Law Firm is a national litigation firm. It has launched a formal investigation into Aetna Medicare Advantage plans. These plans operate under CVS Health Corporation (“CVS”). The firm investigates potential breach of contract and related violations of state laws.

Furthermore, the investigation centers on a serious allegation. CVS may have used artificial intelligence to wrongfully deny prior authorizations. These denials specifically affected post-acute care — care that patients need after a hospital stay.

What Is Post-Acute Care?

Understanding the Care Patients Depend On

Post-acute care includes medical services that follow a hospitalization. Patients often need this care to recover safely and fully. Examples include skilled nursing facilities, rehabilitation centers, and home health services.

Additionally, insurance contracts typically guarantee this care. Policyholders pay premiums with the expectation of receiving it. Therefore, any unauthorized denial can put patient health at serious risk.

How AI Was Used to Deny Claims

AI Algorithms Replaced Medical Professionals

CVS contracts with policyholders contain a clear requirement. Qualified medical professionals must review and approve prior authorization decisions. However, evidence suggests CVS violated this requirement.

Instead of relying on doctors, CVS reportedly used an artificial intelligence program. This AI tool screened policyholder claims before any medical professional reviewed them. As a result, many patients received denials that may not have been medically justified.

Moreover, this practice raises a critical legal question. Did CVS knowingly bypass its contractual obligations? The Schall Law Firm believes the answer warrants thorough investigation.

Senate Scrutiny of CVS Health

Lawmakers Take Aim at AI-Driven Denials

The U.S. Senate has recently examined CVS’s AI practices. Senators raised concerns about automated denial systems used by major insurers. Consequently, CVS came under direct regulatory and legislative pressure.

In addition, this Senate scrutiny has amplified public awareness. Many Medicare Advantage enrollees now question whether their claims received fair review. The investigation by the Schall Law Firm aligns with growing national concern over insurer accountability.

Your Rights as a Policyholder

Know What Your Contract Guarantees

Policyholders have legal protections under their insurance contracts. CVS must follow the terms it agreed to. Specifically, it must ensure that medical professionals — not algorithms — make prior authorization decisions.

However, if CVS failed to honor this requirement, affected policyholders may have legal recourse. Thus, understanding your rights is the first step toward seeking justice. You do not have to accept an improper denial silently.

How to Join the Investigation

Steps to Connect with the Schall Law Firm

The Schall Law Firm is actively seeking affected policyholders. If CVS/Aetna denied your post-acute care authorization, you may qualify to participate. Contact the firm directly to discuss your situation.

Furthermore, joining an investigation carries no immediate obligation. You can share your experience and learn whether your denial involved AI screening. Taking this step protects both your interests and those of other Medicare Advantage members.

Frequently Asked Questions

Who does this investigation affect?

This investigation affects current and former Aetna Medicare Advantage policyholders. Specifically, it targets those who experienced post-acute care authorization denials.

What is the legal basis for the claims?

The claims rest on breach of contract and state law violations. CVS allegedly failed to provide the human medical review its contracts required.

Does participating cost anything?

Typically, initial consultations with the Schall Law Firm are free. You should confirm directly with the firm regarding any costs.